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Abstract 
 
Refractory ascites is difficult to treat by restriction of salt and repeated paracentesis which have been the mainstay of 
treating it for a long time. Sapheno-peritoneal shunts have been performed in patients with refractory ascites . Here, 
we evaluated the use of saphenous vein to be anastomosed to the peritoneam to drain the refractory ascites. Nine  
patients (7 male, median age 45 years, range 17 - 69) with tense refractory ascites associated with  liver cirrhosis, 
perioprtal fibrosis and end stage renal diseases underwent sapheno-peritoneal anastomosis by mobilizing and rotating  
the proximal vein in order to be anastomosed to peritoneum in the lower abdomen . All procedures were performed 
under local anaesthesia. Thirty-day mortality was 22% (2) patient. Morbidity included fluid leakage in 1 (11%), and 
wound infection in 1 (11%). Hospital stay (median) was 16 days (range 11 to 23). In the short term (median of 2 
months) significant reduction in body weight and abdominal girth was seen in 9 (90%), 6 (60%) were not on 
diuretics while 3 (30%) continued to remain on reduced doses of diuretic. Furthermore, 7 (70%) did not require 
paracentesis. At 2-year follow-up, 5 (45%) patients died and 3 succumbed during follow-up. The remaining 3 were 
all in active employment, 1 was off diuretics, and 2 were on reduced doses. All 3 patients maintained reduced body 
weights and abdominal girths compared with preoperative values. Saphenous-peritoneal shunt appears a simple, safe, 
and cost effective method of achieving long-term control of refractory ascites. The use of autogenous shunt is an 
added advantage over prosthetic shunts for drainage of ascitic fluid. 
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Introduction 
 
Sapheno-peritoneal shunt plays a major role in 
management of refractory ascites secondary to liver 
cirrhosis, periportal fibrosis or ESRD (1, 2, 3, 4). It is a 
drainage procedure with return of the ascetic fluid into 
the circulation depending on pressure gradient between 
the peritoneal cavity and the venous system, there some 
system which permit active flow management like 
denevers shunt) (5,6). However, the only disadvantage 
is the higher cost. Sapheno-peritoneal shunt is an option 
where the native long saphenous vein is used as a 
drainage procedure with one way ascites flow guarded 
by the natural saphenous vein valves (7,8).  
 
Materials and Method 
 
Between 2009 and 2011, we performed -peritoneal 
shunts in 9 patients (7 patients with liver cirrhosis and 2 
with end stage renal disease) (Fig1). The criteria 
considered for performing SFS included assessment of  
patency of the femero-iliocaval venous system and a 
good length of the long saphenous vein with sufficient, 
competent valves. 
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Figure 1: A patient with refractory ascites 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: The saphenous vein being anastomosed to the 
peritoneum 
 
The procedure was performed under local anaesthetic 
infiltration using marcaine and lidocaine according to 
the body weight. All patients received antibiotics 
preoperatively; the long saphenous vein was exposed 
through a vertical incision. All branches were ligated 
and divided about 15- 20 cms from the sapheno-
femoral junction, then flushed with heparin- saline and 
competence of the valves was checked by absence of 
retrograde flow. 
 
The peritoneal cavity was approached through a small 
oblique lower abdominal incision, dividing the 
external, internal oblique and transverse abdominis 
muscles till the parietal peritoneam was exposed. A 
tunnel was made between the two incisions bringing 
the long saphenous vein towards the abdomen, 
avoiding any bend. The peritoneum was opened and 
anastomosed with the spatulated saphenous vein using 
prolene 6/0. This procedure was facilitated by 
positioning the patient in Trendelenburg`s position 
(Fig 2, 3). 
 
The wounds were closed in layers without any drain. 
Follow up of the patients were done by assessing the 
symptoms:- dyspnoea,  abdominal distension in the 
ability to perform daily activity and signs abdominal 
girth, vital signs, blood pressure, urine output  renal 
profile and total protein and albumin level, and the 
need for paracentesis. 
 
Results 
 
SFS was performed in 9 patients, 7 of them were 
males and 2 were females (age range from 17 - 65 
years). Seven of them were having liver cirrhosis and 
periportal fibrosis and 2 with end stage renal diseases. 
Procedures were successful in all patients, one patient 
hds leak from the wound. Three patients died, 2 of 
them due to liver failure and septic shock 2 weeks 
following the procedure, while the 3rd
 
 one after 3 
month due to end stage renal disease and abdominal 
tuberculosis. All patients showed remarkable 
improvement regarding their symptoms with sound 
decrease in the abdominal girth and improvement in 
the urine output, blood pressure, and level of 
consciousness, renal profile and liver function. 
One patient had a leak from the anastamosis site which 
required a revisionary exploration 6 patients 
discharged in 3rd
 
 post operative day in a good 
condition. Short term followup within 3 months 
showed functioning shunt in 5 patients without any 
need for paracentesis. Only in one patient the shunt 
was blocked after 10 weeks and required paracentesis. 
Discussion 
 
Refractory ascites is a clinical condition for which a 
few number of therapeutic options may be offered 
such as; diuresis and sodium restriction, paracentesis 
and surgical shunts (Le veen shunt, Denever shunt and 
saphenoperitoneal shunt (2, 3, and 4).  
 
The absence of a single, effective treatment for this 
condition is due to the complexity of its nature (3, 4).  
 
saphenopertoneal shunting has been mentioned in the 
literature as an effective procedure  with many 
physiological benefits in term of  increasing renal 
blood flow, retaining albumin and nutrients and 
improving nutritional status, encouraging mobility and 
respiration, increasing duiresis, decreasing attempts of 
paracentesis, hospital stay and risk of infection (7,8).  
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Figure 3: Groin and abdominal incisions with the vein being 
tunnelled 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Doppler ultrasound showing flow in the 
saphenoperitoneal shunt 
 
saphenoperotoneal  shunt  seems to be as a safe,  
simple and effective method for management of 
refractory ascites, the use of the autogenous saphenous 
vein for drainage adds more advantages over the 
synthetic ones (8) . 
 
 Here in our study, the patients are selected, history 
and physical examination are obtained, doppler 
ultrasound for the saphenous vein, femoral vein to rule 
out any disease or occlusion. Post operatively patients 
are followed up by serial measurement of the 
abdominal girth, blood pressure, urine output, full 
blood count and liver function tests and doppler 
ultrasound to assess the patency of the shunt (Fig 4). 
 
Thirty-day mortality was 22%. Morbidity included 
wound leak 11% and wound infection in 11%. 
Hospital stay was 7 days (range 3 to 21). Compared 
with the other studies, hospital stay in our study is a 
little bit shorter (9), there is also remarkable 
improvement in urine output, blood pressure and the 
blood parameters and a decrease in morbidity (8). 
These complications are preventable and do not affect 
the general out come. Zervos et al reported loss of 
function due to occlusion in 52 %, infection in 18% 
and in other series mortality rate was 60 % (9). 
 
Conclusion 
 
Sapheno-peritoneal shunt seems to be a good 
procedure for management of refractory ascites, it is 
cheap, effective and convenient for the patient besides 
being done under local anaesthesia. Further 
comparative studies are required to validate these 
results so as to encourage using this technique. 
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